Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 15 studies | 31% ± 15% | |
peripheral blood | 15 studies | 29% ± 8% | |
brain | 14 studies | 27% ± 12% | |
eye | 9 studies | 31% ± 10% | |
kidney | 8 studies | 23% ± 6% | |
heart | 5 studies | 26% ± 5% | |
uterus | 5 studies | 31% ± 13% | |
intestine | 4 studies | 20% ± 5% | |
bone marrow | 4 studies | 28% ± 13% | |
lymph node | 4 studies | 30% ± 3% | |
pancreas | 3 studies | 30% ± 11% | |
prostate | 3 studies | 20% ± 3% | |
liver | 3 studies | 26% ± 12% | |
adipose | 3 studies | 39% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 8065.27 | 1443 / 1445 | 100% | 223.42 | 183 / 183 |
lung | 100% | 15268.78 | 577 / 578 | 100% | 163.64 | 1155 / 1155 |
ovary | 100% | 6671.58 | 180 / 180 | 100% | 82.51 | 428 / 430 |
thymus | 100% | 9106.99 | 652 / 653 | 98% | 128.84 | 592 / 605 |
uterus | 99% | 5497.99 | 169 / 170 | 97% | 126.86 | 447 / 459 |
kidney | 100% | 12038.21 | 89 / 89 | 97% | 109.72 | 872 / 901 |
brain | 97% | 4326.53 | 2554 / 2642 | 100% | 165.91 | 704 / 705 |
bladder | 100% | 7446.14 | 21 / 21 | 96% | 105.60 | 484 / 504 |
prostate | 99% | 6234.49 | 243 / 245 | 96% | 81.28 | 484 / 502 |
intestine | 99% | 5587.15 | 961 / 966 | 94% | 80.79 | 496 / 527 |
stomach | 97% | 4746.75 | 349 / 359 | 96% | 96.55 | 274 / 286 |
adrenal gland | 100% | 21634.17 | 258 / 258 | 93% | 87.63 | 213 / 230 |
breast | 100% | 7417.35 | 459 / 459 | 92% | 85.30 | 1034 / 1118 |
skin | 100% | 19861.23 | 1801 / 1809 | 91% | 78.11 | 429 / 472 |
pancreas | 73% | 2346.82 | 239 / 328 | 98% | 122.82 | 175 / 178 |
liver | 64% | 2754.76 | 144 / 226 | 59% | 41.27 | 238 / 406 |
spleen | 100% | 8922.10 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 10382.81 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 9583.09 | 1333 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 10375.23 | 911 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 123.48 | 43 / 45 |
lymph node | 0% | 0 | 0 / 0 | 93% | 88.75 | 27 / 29 |
heart | 87% | 4195.84 | 750 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 46% | 19.72 | 37 / 80 |
muscle | 28% | 656.65 | 223 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002052 | Biological process | positive regulation of neuroblast proliferation |
GO_0002071 | Biological process | glandular epithelial cell maturation |
GO_0032722 | Biological process | positive regulation of chemokine production |
GO_0010468 | Biological process | regulation of gene expression |
GO_0006089 | Biological process | lactate metabolic process |
GO_0046716 | Biological process | muscle cell cellular homeostasis |
GO_1903377 | Biological process | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway |
GO_0042541 | Biological process | hemoglobin biosynthetic process |
GO_0001922 | Biological process | B-1 B cell homeostasis |
GO_0001947 | Biological process | heart looping |
GO_0002062 | Biological process | chondrocyte differentiation |
GO_0097152 | Biological process | mesenchymal cell apoptotic process |
GO_0061030 | Biological process | epithelial cell differentiation involved in mammary gland alveolus development |
GO_2000434 | Biological process | regulation of protein neddylation |
GO_0051402 | Biological process | neuron apoptotic process |
GO_0001666 | Biological process | response to hypoxia |
GO_1902895 | Biological process | positive regulation of miRNA transcription |
GO_1901526 | Biological process | positive regulation of mitophagy |
GO_0045926 | Biological process | negative regulation of growth |
GO_0032909 | Biological process | regulation of transforming growth factor beta2 production |
GO_0070244 | Biological process | negative regulation of thymocyte apoptotic process |
GO_0010573 | Biological process | vascular endothelial growth factor production |
GO_0001525 | Biological process | angiogenesis |
GO_0010039 | Biological process | response to iron ion |
GO_0003151 | Biological process | outflow tract morphogenesis |
GO_0046886 | Biological process | positive regulation of hormone biosynthetic process |
GO_0070101 | Biological process | positive regulation of chemokine-mediated signaling pathway |
GO_0097411 | Biological process | hypoxia-inducible factor-1alpha signaling pathway |
GO_0001755 | Biological process | neural crest cell migration |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0001892 | Biological process | embryonic placenta development |
GO_0045766 | Biological process | positive regulation of angiogenesis |
GO_2000273 | Biological process | positive regulation of signaling receptor activity |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0007165 | Biological process | signal transduction |
GO_1902894 | Biological process | negative regulation of miRNA transcription |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0032007 | Biological process | negative regulation of TOR signaling |
GO_0071347 | Biological process | cellular response to interleukin-1 |
GO_0006110 | Biological process | regulation of glycolytic process |
GO_0008542 | Biological process | visual learning |
GO_0003208 | Biological process | cardiac ventricle morphogenesis |
GO_1900017 | Biological process | positive regulation of cytokine production involved in inflammatory response |
GO_0006879 | Biological process | intracellular iron ion homeostasis |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0045648 | Biological process | positive regulation of erythrocyte differentiation |
GO_0000302 | Biological process | response to reactive oxygen species |
GO_0061072 | Biological process | iris morphogenesis |
GO_0030949 | Biological process | positive regulation of vascular endothelial growth factor receptor signaling pathway |
GO_0060574 | Biological process | intestinal epithelial cell maturation |
GO_0019896 | Biological process | axonal transport of mitochondrion |
GO_0048546 | Biological process | digestive tract morphogenesis |
GO_0032963 | Biological process | collagen metabolic process |
GO_0007405 | Biological process | neuroblast proliferation |
GO_0035162 | Biological process | embryonic hemopoiesis |
GO_0043536 | Biological process | positive regulation of blood vessel endothelial cell migration |
GO_0002248 | Biological process | connective tissue replacement involved in inflammatory response wound healing |
GO_0001678 | Biological process | intracellular glucose homeostasis |
GO_0061298 | Biological process | retina vasculature development in camera-type eye |
GO_0035774 | Biological process | positive regulation of insulin secretion involved in cellular response to glucose stimulus |
GO_0034599 | Biological process | cellular response to oxidative stress |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0030502 | Biological process | negative regulation of bone mineralization |
GO_0010575 | Biological process | positive regulation of vascular endothelial growth factor production |
GO_0051541 | Biological process | elastin metabolic process |
GO_2001054 | Biological process | negative regulation of mesenchymal cell apoptotic process |
GO_0010634 | Biological process | positive regulation of epithelial cell migration |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0001837 | Biological process | epithelial to mesenchymal transition |
GO_0031929 | Biological process | TOR signaling |
GO_2000378 | Biological process | negative regulation of reactive oxygen species metabolic process |
GO_0071542 | Biological process | dopaminergic neuron differentiation |
GO_0014850 | Biological process | response to muscle activity |
GO_0035773 | Biological process | insulin secretion involved in cellular response to glucose stimulus |
GO_0098586 | Biological process | cellular response to virus |
GO_0001938 | Biological process | positive regulation of endothelial cell proliferation |
GO_0030282 | Biological process | bone mineralization |
GO_1903715 | Biological process | regulation of aerobic respiration |
GO_0032364 | Biological process | intracellular oxygen homeostasis |
GO_0021987 | Biological process | cerebral cortex development |
GO_0007595 | Biological process | lactation |
GO_0051000 | Biological process | positive regulation of nitric-oxide synthase activity |
GO_0021502 | Biological process | neural fold elevation formation |
GO_0071456 | Biological process | cellular response to hypoxia |
GO_0005634 | Cellular component | nucleus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016604 | Cellular component | nuclear body |
GO_0031514 | Cellular component | motile cilium |
GO_0000791 | Cellular component | euchromatin |
GO_0032991 | Cellular component | protein-containing complex |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_1904115 | Cellular component | axon cytoplasm |
GO_0016607 | Cellular component | nuclear speck |
GO_0005829 | Cellular component | cytosol |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0051879 | Molecular function | Hsp90 protein binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0001223 | Molecular function | transcription coactivator binding |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0070888 | Molecular function | E-box binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0140537 | Molecular function | transcription regulator activator activity |
GO_0001217 | Molecular function | DNA-binding transcription repressor activity |
GO_0042826 | Molecular function | histone deacetylase binding |
GO_0019899 | Molecular function | enzyme binding |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0000987 | Molecular function | cis-regulatory region sequence-specific DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0002039 | Molecular function | p53 binding |
GO_0001216 | Molecular function | DNA-binding transcription activator activity |
GO_0005515 | Molecular function | protein binding |
GO_0016922 | Molecular function | nuclear receptor binding |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0019901 | Molecular function | protein kinase binding |
Gene name | HIF1A |
Protein name | Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) Hypoxia-inducible factor 1-alpha |
Synonyms | hCG_21199 MOP1 PASD8 BHLHE78 |
Description | FUNCTION: Functions as a master transcriptional regulator of the adaptive response to hypoxia . Under hypoxic conditions, activates the transcription of over 40 genes, including erythropoietin, glucose transporters, glycolytic enzymes, vascular endothelial growth factor, HILPDA, and other genes whose protein products increase oxygen delivery or facilitate metabolic adaptation to hypoxia . Plays an essential role in embryonic vascularization, tumor angiogenesis and pathophysiology of ischemic disease . Heterodimerizes with ARNT; heterodimer binds to core DNA sequence 5'-TACGTG-3' within the hypoxia response element (HRE) of target gene promoters (By similarity). Activation requires recruitment of transcriptional coactivators such as CREBBP and EP300 . Activity is enhanced by interaction with NCOA1 and/or NCOA2 . Interaction with redox regulatory protein APEX1 seems to activate CTAD and potentiates activation by NCOA1 and CREBBP . Involved in the axonal distribution and transport of mitochondria in neurons during hypoxia . .; FUNCTION: (Microbial infection) Upon infection by human coronavirus SARS-CoV-2, is required for induction of glycolysis in monocytes and the consequent pro-inflammatory state . In monocytes, induces expression of ACE2 and cytokines such as IL1B, TNF, IL6, and interferons . Promotes human coronavirus SARS-CoV-2 replication and monocyte inflammatory response . . |
Accessions | D0VY79 Q16665 ENST00000323441.10 [Q16665-2] A8MYV6 ENST00000539097.2 [Q16665-3] ENST00000394997.5 ENST00000337138.9 [Q16665-1] |